Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer

被引：0
|
作者：
Frederik A. Verburg
Uwe Mäder
Markus Luster
Heribert Hänscheid
Christoph Reiners
机构：
[1] University of Würzburg,Department of Nuclear Medicine
[2] University of Würzburg,Comprehensive Cancer Center Mainfranken
[3] RWTH University Hospital Aachen,Department of Nuclear Medicine
[4] University Hospital Giessen and Marburg,Department of Nuclear Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2015年 / 42卷
关键词：
Differentiated thyroid carcinoma; Complete remission; I Therapy; Paediatric cancer; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1390 / 1398
页数：8
相关论文
共 50 条
  • [1] Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer
    Verburg, Frederik A.
    Maeder, Uwe
    Luster, Markus
    Haenscheid, Heribert
    Reiners, Christoph
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (09) : 1390 - 1398
  • [2] Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer
    Taylor, H
    Hyer, S
    Vini, L
    Pratt, B
    Cook, G
    Harmer, C
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (05) : 649 - 653
  • [3] Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation
    Salvatore, B.
    Paone, G.
    Klain, M.
    Storto, G.
    Nicolai, E.
    D'Amico, D.
    Della Morte, A. M.
    Pace, L.
    Salvatore, M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 52 (01): : 2 - 8
  • [4] TSH ≥30 mU/lmU/l may not be necessary for successful 131I remnant ablation after total thyroidectomy in patients with differentiated thyroid cancer
    Shen, Chentian
    Ju, Nianting
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [5] Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer
    Gortan, Fatma Arzu
    Yuksel, Alptug Ozer
    Gulaldi, Nedim Cuneyt Murat
    Coskun, Nazim
    Akca, Ceren Deniz Kapulu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 260 - 268
  • [6] The prevalence of thyroglossal tract thyroid tissue on SPECT/CT following 131I ablation therapy after total thyroidectomy for thyroid cancer
    Barber, Thomas W.
    Cherk, Martin H.
    Topliss, Duncan J.
    Serpell, Jonathan W.
    Yap, Kenneth S. K.
    Bailey, Michael
    Kalff, Victor
    CLINICAL ENDOCRINOLOGY, 2014, 81 (02) : 266 - 270
  • [7] Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer
    Leblanc, G
    Tabah, R
    Liberman, M
    Sampalis, J
    Younan, R
    How, J
    SURGERY, 2004, 136 (06) : 1275 - 1278
  • [8] Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without 131I Ablation
    Matrone, Antonio
    Latrofa, Francesco
    Torregrossa, Liborio
    Piaggi, Paolo
    Gambale, Carla
    Faranda, Alessio
    Ricci, Debora
    Agate, Laura
    Molinaro, Eleonora
    Basolo, Fulvio
    Vitti, Paolo
    Elisei, Rossella
    THYROID, 2018, 28 (07) : 871 - 879
  • [9] Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Doi, SAR
    Woodhouse, NJY
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 765 - 773
  • [10] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
12345